New York, NY -- (SBWIRE) -- 01/20/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Health Care REIT, Inc. (NYSE:HCN), Prima Biomed Ltd. (NASDAQ:PBMD), MBIA Inc. (NYSE:MBI), CEL-SCI Corporation (NYSEMKT:CVM)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Health Care REIT, Inc. (NYSE:HCN) opened its shares at the price of $56.20 for the day. Its closing price was $55.59 after losing -0.84% for the day. The company traded with the total volume of 2.00 million shares, while its average trading volume remained 2.29 million shares. The beta of HCN stands at 0.76. Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States.
Has HCN Found The Bottom and Ready To Move Up? Find Out Here
Prima Biomed Ltd. (NASDAQ:PBMD) percentage change surged +6.72% to close at $1.43 with the total traded volume of 1.58 million shares, and average volume of 193,332.00 shares. The 52 week range of the stock remained $0.82 - $4.54, while its day lowest price was $1.40 and it hit its day highest price at $1.65. Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia.
Will PBMD Continue To Move Higher? Find Out Here
MBIA Inc. (NYSE:MBI) started its trading session with the price of $11.91 and closed at $11.52 by scoring -3.19%. MBI’s stocks traded with total volume of 1.96 million shares, while the average trading volume remained 2.43 million shares. The beta of MBI stands at 2.36. Day range of the stock was $11.42 -$11.92. MBIA Inc., together with its subsidiaries, provides financial guarantee insurance and related reinsurance, advisory, and portfolio services for the public and structured finance markets; and asset management advisory services in the United States and internationally.
Will MBI Get Buyers Even After The Recent Rally? Find Out Here
CEL-SCI Corporation (NYSEMKT:CVM) ended its day with the loss of -4.95% and closed at the price of $0.86 after opening at $0.93. Stock traded during its last trading session with the total volume of 1.57 million shares, as compared to its average volume of 1.47 million shares. CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer.
Why Should Investors Buy CVM After the Recent Fall? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)